Author： Turajlic Samra Ali Zohra Yousaf Nadia Larkin James
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.6, 2013-09, pp. : 739-749
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New RAF kinase inhibitors in cancer therapy
By Martin-Liberal Juan Larkin James
Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. :
Access to resources
Recommend
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry, Vol. 3, Iss. 3, 2003-01 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :
Kinase Inhibitors in Cancer Therapy: A Look Ahead
By Sedlacek H.
Drugs, Vol. 59, Iss. 3, 2000-03 ,pp. :
Development of RET Kinase Inhibitors for Targeted Cancer Therapy
Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. :